Decibel Therapeutics, Inc. (DBTX) has a market capitalization of $123.37M and trades at $4.91. The 52-week range is 1.61-5.4.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-2.52.
The stock has a beta of -0.40, operates in the Healthcare sector.
